Journal
SMALL
Volume 13, Issue 10, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201603121
Keywords
-
Categories
Funding
- National Institutes of Health Award [NHLBIHL118498, NIBIBEB012575, NCICA182670]
- National Science Foundation (NSF) [DMR1313553, CMMI1266116, CBET-BME1330663]
- PA Tobacco Settlement Fund [4100062216]
Ask authors/readers for more resources
Although tremendous efforts have been made on targeted drug delivery systems, current therapy outcomes still suffer from low circulating time and limited targeting efficiency. The integration of cell-mediated drug delivery and theranostic nanomedicine can potentially improve cancer management in both therapeutic and diagnostic applications. By taking advantage of innate immune cell's ability to target tumor cells, the authors develop a novel drug delivery system by using macrophages as both nanoparticle (NP) carriers and navigators to achieve cancerspecific drug delivery. Theranostic NPs are fabricated from a unique polymer, biodegradable photoluminescent poly (lactic acid) (BPLP-PLA), which possesses strong fluorescence, biodegradability, and cytocompatibility. In order to minimize the toxicity of cancer drugs to immune cells and other healthy cells, an anti-BRAF V600E mutant melanoma specific drug (PLX4032) is loaded into BPLP-PLA nanoparticles. Muramyl tripeptide is also conjugated onto the nanoparticles to improve the nanoparticle loading efficiency. The resulting nanoparticles are internalized within macrophages, which are tracked via the intrinsic fluorescence of BPLP-PLA. Macrophages carrying nanoparticles deliver drugs to melanoma cells via cell-cell binding. Pharmacological studies also indicate that the PLX4032 loaded nanoparticles effectively kill melanoma cells. The self-powered immune cellmediated drug delivery system demonstrates a potentially significant advancement in targeted theranostic cancer nanotechnologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available